BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17405688)

  • 21. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A special issue dedicated to a complex tissue.
    Fenton SE
    Reprod Toxicol; 2015 Jul; 54():1-5. PubMed ID: 25986312
    [No Abstract]   [Full Text] [Related]  

  • 23. Metals and breast cancer.
    Byrne C; Divekar SD; Storchan GB; Parodi DA; Martin MB
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):63-73. PubMed ID: 23338949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Press statement. Breast cancer and hormone therapy: a looking-glass mirror?
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2007 Oct; 10(5):356-7. PubMed ID: 17852137
    [No Abstract]   [Full Text] [Related]  

  • 25. Interactions between hormones and chemicals in breast cancer.
    Safe SH
    Annu Rev Pharmacol Toxicol; 1998; 38():121-58. PubMed ID: 9597151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine disruptors: can biological effects and environmental risks be predicted?
    Witorsch RJ
    Regul Toxicol Pharmacol; 2002 Aug; 36(1):118-30. PubMed ID: 12383724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immune system as a target for environmental chemicals: Xenoestrogens and other compounds.
    Inadera H
    Toxicol Lett; 2006 Jul; 164(3):191-206. PubMed ID: 16697129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.
    Buteau-Lozano H; Velasco G; Cristofari M; Balaguer P; Perrot-Applanat M
    J Endocrinol; 2008 Feb; 196(2):399-412. PubMed ID: 18252963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oestrogens and the environment.
    Olea N; Olea-Serrano MF
    Eur J Cancer Prev; 1996 Dec; 5(6):491-6. PubMed ID: 9061282
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms, proof, and unmet needs: the perspective of a cancer activist.
    Steingraber S
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):685-7. PubMed ID: 9168015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Xenoestrogens--danger for the future generations?].
    Sirakov M
    Akush Ginekol (Sofiia); 2004; 43(4):39-45. PubMed ID: 15318543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nongenomic signaling pathways of estrogen toxicity.
    Watson CS; Jeng YJ; Kochukov MY
    Toxicol Sci; 2010 May; 115(1):1-11. PubMed ID: 19955490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen, alcohol consumption, and breast cancer.
    Fernandez SV
    Alcohol Clin Exp Res; 2011 Mar; 35(3):389-91. PubMed ID: 22132831
    [No Abstract]   [Full Text] [Related]  

  • 34. Hormone therapy and breast cancer risk.
    Foidart JM; Desreux J; Pintiaux A; Gompel A
    Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical hypothesis: xenoestrogens as preventable causes of breast cancer.
    Davis DL; Bradlow HL; Wolff M; Woodruff T; Hoel DG; Anton-Culver H
    Environ Health Perspect; 1993 Oct; 101(5):372-7. PubMed ID: 8119245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aromatic amines and biomarkers of human exposure.
    Talaska G; Al-Zoughool M
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2003 Nov; 21(2):133-64. PubMed ID: 15845223
    [No Abstract]   [Full Text] [Related]  

  • 37. Physical activity as a negative modulator of estrogen-induced breast cancer.
    Coyle YM
    Cancer Causes Control; 2008 Dec; 19(10):1021-9. PubMed ID: 18543069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interspecies response to carcinogens and oestrogens.
    Drill VA
    Food Cosmet Toxicol; 1981 Oct; 19(5):607-10. PubMed ID: 7308904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancer.
    Davis DL; Telang NT; Osborne MP; Bradlow HL
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):571-6. PubMed ID: 9167997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-think HRT: behind the scene of perceptions.
    Pines A
    Climacteric; 2008; 11(6):443-6. PubMed ID: 18991073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.